Delivery of protein therapeutics has been a target for neural regeneration in a host of CNS diseases and injuries including Parkinson's, Alzheimer's, spinal cord injury, and stroke, but their targeted, sustained delivery is a challenge to translational medicine due to fast clearance from the target site or degradation within a couple hours of delivery.